Hantavirus vaccine in 2026?
Gotcha risk
Low0 of 4 factors flagged
Watch for: The market defines clear and specific conditions for resolution.
Read the full assessment
The market defines clear and specific conditions for resolution. It requires full approval by the U.S. FDA for a human vaccine targeting Hantavirus (explicitly covering HPS and HFRS) on or before December 31, 2026, at 11:59 PM ET. The primary resolution source is the official FDA licensed vaccines database, with credible media consensus as an auxiliary source. Note that the rules require full FDA approval rather than emergency use authorization.
- Resolver
- Low
- Timing
- Low
- Wording
- Low
- Exceptions
- Low
AI-generated analysis · google/gemini-3.7-flash ·
Current price
3%
chance↔ ±0 pts · 24h
Why it moved
No big moves in the last 7 days.
Resolution rules
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the FDA, including its list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states), however a consensus of credible reporting may also be used.
Market explained
This market measures whether the U.S. Food and Drug Administration grants full approval to a human Hantavirus vaccine by December 31, 2026.
How it resolves
The market resolves to Yes if any human vaccine against Hantavirus—including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)—receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, at 11:59 PM ET. The market resolves to No if no such vaccine receives full FDA approval by this deadline. Resolution relies primarily on official FDA information, such as its list of licensed vaccines, though a consensus of credible reporting may also be used.
Resolution source
Official information from the FDA, including its list of approved vaccines, or a consensus of credible reporting
AI-generated analysis · google/gemini-3.7-flash ·